December 15, 2026, 12pm-1pm ET
Genetic, pathologic and hormonal contributions to psychosis in Alzheimer’s disease
Speaker: Corinne Fischer
This presentation will examine putative mechanisms underlying psychosis in Alzheimer’s disease and how sex, APOE4 status and brain pathology may play a role. Specifically, we will examine how APOE4 status interacts with sex and pathology to determine psychotic phenotypes and how this knowledge may inform treatment. We will also examine the protective role of estrogen therapy in Alzheimer’s disease-related psychosis.
Please note that registration is required to attend. Click here to register.
Past webinars
What are you looking for?
Staging Alzheimer’s disease in vivo
August 15, 2022
Indigenous engagement and data governance in practice
May 26, 2022
Open access learning resources:
Good Data (2019)
The State of Open Data (2019)
Indigenous Data Sovereignty (2016)Communicating about medications and other therapies in a way that is meaningful to people with lived experience of dementia
March 29, 2022
Arts-based knowledge translation: Piece of mind
January 19, 2022
Biomarkers in research and care: Applications and implications
July 21, 2021
Situating the “new dementia” – context and diversity in dementia prevention
April 8, 2021
Researcher-entrepreneurs panel
February 2, 2021
Increasing participant diversity in health research: Literature review and lessons learned from the ENGAGE trial
September 8, 2020
Improbable encounter
August 7, 2020
From 0 to 100 in remote dementia research: A practical guide
July 9, 2020






